Simplex Trading
PASG icon

Simplex Trading’s Passage Bio PASG Stock Holding History

Simplex Trading’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,149
Closed -$33K – 9787
2025
Q2 		$33K Buy
4,149
+32
+0.8% +$234 ﹤0.01% 6319
2025
Q1 		$29K Buy
4,117
+4,088
+14,097% +$44.2K ﹤0.01% 6276
2024
Q4 		$0 Buy
+29
New +$378 ﹤0.01% 9342
2024
Q1 		– Sell
-104
Closed -$2.5K – 9595
2023
Q4 		$2K Buy
+104
New +$1.44K ﹤0.01% 8323
2023
Q2 		– Sell
-16
Closed – – 9678
2023
Q1 		$0 Buy
+16
New +$434 ﹤0.01% 9843
2022
Q2 		– Sell
-36
Closed -$1.68K – 10786
2022
Q1 		$2K Buy
+36
New +$2.97K ﹤0.01% 9900
2021
Q4 		– Sell
-29
Closed -$4.74K – 11176
2021
Q3 		$8K Buy
29
+10
+53% +$2.38K ﹤0.01% 9063
2021
Q2 		$5K Buy
19
+13
+217% +$4.02K ﹤0.01% 9467
2021
Q1 		$2K Buy
+6
New +$2.56K ﹤0.01% 8477

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's PASG Position: Q3 2025 in Review

Simplex Trading sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 4,149 shares — an estimated $33K sold.

Simplex Trading first reported a position in PASG in Q1 2021 and held it in 9 quarters. The position peaked at $33K in Q2 2025. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Simplex Trading reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 4,149 Passage Bio shares in Q3 2025, an estimated $33K.
  • Simplex Trading first reported a position in Passage Bio in Q1 2021 and held it in 9 quarters.
  • Simplex Trading's Passage Bio position peaked at $33K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.